(Q43213552)

16 November 2017

title

The effect of long-term danazol prophylaxis on liver function in hereditary angioedema-a longitudinal study (English)

1 reference

16 November 2017

Henriette Farkas

1

1 reference

16 November 2017

Ibolya Czaller

2

1 reference

16 November 2017

Dorottya Csuka

3

1 reference

16 November 2017

Anikó Vas

4

1 reference

16 November 2017

Szilvia Valentin

5

1 reference

16 November 2017

Lilian Varga

6

1 reference

16 November 2017

Gábor Széplaki

7

1 reference

16 November 2017

László Jakab

8

1 reference

16 November 2017

George Füst

9

1 reference

16 November 2017

Zoltán Prohászka

10

1 reference

16 November 2017

George Harmat

11

1 reference

16 November 2017

Beata Visy

12

1 reference

16 November 2017

István Karádi

13

1 reference

16 November 2017

publication date

19 December 2009

1 reference

European Journal of Clinical Pharmacology

16 November 2017

published in

1 reference

16 November 2017

volume

66

1 reference

16 November 2017

issue

4

1 reference

16 November 2017

page(s)

419-426

1 reference

Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report

16 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-009-0771-Z

Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives

21 January 2018

1 reference

12 December 2020

Hepatocellular carcinoma after danazol therapy

1 reference

12 December 2020

Characterisation of a new C1 inhibitor mutant in a patient with hepatocellular carcinoma

1 reference

12 December 2020

Hereditary angioedema: the clinical syndrome and its management in the United States

1 reference

12 December 2020

Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P.

1 reference

12 December 2020

Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new?

1 reference

12 December 2020

Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema

1 reference

12 December 2020

Hereditary angioneurotic oedema in two families

1 reference

12 December 2020

Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema

1 reference

12 December 2020

Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol

1 reference

12 December 2020

Hepatic tumours induced by anabolic steroids in an athlete

1 reference

12 December 2020

Long-term therapy of hereditary angioedema with danazol.

1 reference

12 December 2020

Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience

1 reference

12 December 2020

Hepatocellular focal nodular hyperplasia after danazol treatment for hereditary angio-oedema

1 reference

12 December 2020

Management of hereditary angioedema in pediatric patients.

1 reference

12 December 2020

C1 inhibitor deficiency: consensus document

1 reference

12 December 2020

Danazol-induced hepatocellular adenomas. A case report and review of the literature

1 reference

12 December 2020

A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids

1 reference

12 December 2020

Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients

1 reference

12 December 2020

Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema.

1 reference

12 December 2020

Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema

1 reference

12 December 2020

A randomized, parallel, comparative study of the efficacy and safety of nafarelin versus danazol in the treatment of endometriosis in Taiwan

1 reference

12 December 2020

Danazol therapy: an unusual aetiology of hepatocellular carcinoma

1 reference

12 December 2020

Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients

1 reference

12 December 2020

C1-inhibitor deficiency and angioedema.

1 reference

12 December 2020

Oxandrolone treatment of childhood hereditary angioedema

1 reference

12 December 2020

Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol.

1 reference

12 December 2020

Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities

1 reference

12 December 2020

Hereditary angioedema: Safety of long-term stanozolol therapy.

1 reference

12 December 2020

Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.

1 reference

12 December 2020

Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.

1 reference

12 December 2020

The long-term safety of danazol in women with hereditary angioedema

1 reference

12 December 2020

Appraisal of danazol prophylaxis for hereditary angioedema

1 reference

12 December 2020

C1̅ Inhibitor: Evidence for Decreased Hepatic Synthesis in Hereditary Angioneurotic Edema

1 reference

12 December 2020

Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00228-009-0771-Z

Identifiers

DOI

1 reference

16 November 2017

1 reference